[
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b001",
    "text": "CME: Continuing Medical Education or Commercial Marketing Efforts?",
    "bbox": [
      118.9,
      72.2,
      496.3,
      85.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b002",
    "text": "Testimony submitted to the Senate Committee on Aging",
    "bbox": [
      157.3,
      100.0,
      458.0,
      113.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b003",
    "text": "Adriane Fugh-Berman MD",
    "bbox": [
      72.0,
      183.4,
      215.3,
      196.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b004",
    "text": "Director, PharmedOut",
    "bbox": [
      72.0,
      197.3,
      192.1,
      210.7
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b005",
    "text": "Department of Physiology and Biophysics",
    "bbox": [
      72.0,
      211.2,
      296.8,
      224.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b006",
    "text": "Georgetown University Medical Center",
    "bbox": [
      72.0,
      225.1,
      280.7,
      238.5
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b007",
    "text": "Box 571460",
    "bbox": [
      72.0,
      239.0,
      139.3,
      252.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b008",
    "text": "Washington DC 20057-1460",
    "bbox": [
      72.0,
      252.9,
      226.7,
      266.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b009",
    "text": "Ajf29@georgetown.edu",
    "bbox": [
      72.0,
      266.8,
      201.0,
      280.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b010",
    "text": "Disclosure: Dr. Fugh-Berman has been a paid expert witness on behalf of plaintiffs in",
    "bbox": [
      72.0,
      350.2,
      525.6,
      363.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 1,
    "block_id": "981_p1_b011",
    "text": "litigation regarding pharmaceutical marketing practices.",
    "bbox": [
      72.0,
      364.0,
      368.8,
      377.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b001",
    "text": "Fugh­Berman, A",
    "bbox": [
      458.8,
      36.0,
      542.6,
      50.1
    ],
    "font_size": 12.0,
    "font_name": "Cambria-Italic",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b002",
    "text": "Continuing medical education (CME) is the pharmaceutical industry’s most",
    "bbox": [
      108.0,
      86.2,
      506.9,
      99.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b003",
    "text": "important marketing tool. The development of marketing messages for a drug starts",
    "bbox": [
      72.0,
      100.0,
      518.2,
      113.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b004",
    "text": "seven to ten years before a drug is submitted for FDA approval. Many of the marketing",
    "bbox": [
      72.0,
      113.8,
      534.9,
      127.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b005",
    "text": "messages that are developed for each product do not mention the drug at all. A ‘pre-",
    "bbox": [
      72.0,
      127.6,
      520.2,
      141.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b006",
    "text": "launch’ marketing message might emphasize the importance of a specific physiologic",
    "bbox": [
      72.0,
      141.4,
      527.5,
      154.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b007",
    "text": "process in order to set the stage for acceptance of a drug that affects that mechanism,",
    "bbox": [
      72.0,
      155.2,
      533.0,
      168.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b008",
    "text": "or might create an unnecessary diagnostic distinction in order to establish a niche for a",
    "bbox": [
      72.0,
      169.0,
      535.0,
      182.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b009",
    "text": "drug entering a crowded market.",
    "bbox": [
      72.0,
      182.8,
      251.3,
      196.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b010",
    "text": "Selling disease",
    "bbox": [
      72.0,
      210.4,
      156.0,
      223.8
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b011",
    "text": "CME is used to sell drugs by selling diseases. As a marketing article called",
    "bbox": [
      108.0,
      224.1,
      508.0,
      237.5
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b012",
    "text": "“Proving the case for investing in CME,” states:“The most significant benefits for",
    "bbox": [
      72.0,
      237.9,
      498.8,
      251.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b013",
    "text": "industry may include creating disease-state awareness and disease state",
    "bbox": [
      72.0,
      251.8,
      464.2,
      265.2
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b014",
    "text": "significance.”i1 Another marketing article notes that:“CME activities are most valuable in",
    "bbox": [
      72.0,
      263.6,
      540.6,
      278.9
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b015",
    "text": "introducing products early in their life cycles or for promoting mature brands with new",
    "bbox": [
      72.0,
      279.4,
      526.2,
      292.8
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b016",
    "text": "indications and new clinical data.”2",
    "bbox": [
      72.0,
      291.3,
      263.0,
      306.6
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b017",
    "text": "Industry-funded CME often emphasizes the severity or prevalence of specific",
    "bbox": [
      108.0,
      306.9,
      519.5,
      320.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b018",
    "text": "conditions in order to prepare, or expand, a market.3 Manipulating physicians’",
    "bbox": [
      72.0,
      318.8,
      487.0,
      334.1
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b019",
    "text": "understanding of the prevalence or severity of medical conditions can lead to",
    "bbox": [
      72.0,
      334.5,
      482.9,
      347.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b020",
    "text": "overtreatment, and expose patients to the adverse effects of drugs without significant",
    "bbox": [
      72.0,
      348.3,
      526.3,
      361.7
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b021",
    "text": "benefit.",
    "bbox": [
      72.0,
      362.1,
      118.1,
      375.5
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b022",
    "text": "The marketing messages imbedded in CME lectures, articles, on-line modules,",
    "bbox": [
      108.0,
      375.9,
      529.6,
      389.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b023",
    "text": "and tests are never advertisements for a specific therapy because physicians will reject",
    "bbox": [
      72.0,
      389.7,
      537.5,
      403.1
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b024",
    "text": "speakers or articles that obviously favor a specific drug. One marketing message might",
    "bbox": [
      72.0,
      403.5,
      536.9,
      416.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b025",
    "text": "emphasize the risks of competing therapies; another the lack of evidence regarding an",
    "bbox": [
      72.0,
      417.3,
      533.6,
      430.7
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b026",
    "text": "over-the-counter remedy.",
    "bbox": [
      72.0,
      431.1,
      210.1,
      444.5
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b027",
    "text": "CME is often used to promote unproven uses of a drug. While it is illegal for a",
    "bbox": [
      108.0,
      444.9,
      522.4,
      458.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b028",
    "text": "drug company to promote off-label use of a drug, CME is not considered promotion and",
    "bbox": [
      72.0,
      458.7,
      538.9,
      472.1
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b029",
    "text": "is not regulated by the FDA.  Physicians can say whatever they want, so are used as",
    "bbox": [
      72.0,
      472.5,
      525.1,
      485.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b030",
    "text": "mouthpieces for marketing messages that would be illegal coming from a company rep.",
    "bbox": [
      72.0,
      486.3,
      542.2,
      499.7
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b031",
    "text": "The academic physicians involved in industry-funded CME may protest, quite",
    "bbox": [
      108.0,
      500.1,
      520.8,
      513.5
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b032",
    "text": "honestly, that they are expressing their independent opinions. However, they are",
    "bbox": [
      72.0,
      513.9,
      502.9,
      527.3
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b033",
    "text": "chosen because what they are saying aligns with a product’s marketing messages, and",
    "bbox": [
      72.0,
      527.7,
      538.2,
      541.1
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b034",
    "text": "as they do so.",
    "bbox": [
      216.8,
      541.5,
      291.5,
      554.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b035",
    "text": "are supported only as long",
    "bbox": [
      72.0,
      541.5,
      216.8,
      554.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b036",
    "text": "4 A physician who expresses doubts about a",
    "bbox": [
      292.0,
      539.6,
      531.1,
      554.9
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b037",
    "text": "Raichle L. Proving the case for investing in CME. Medical Marketing & Media. Jun 1998;",
    "bbox": [
      76.4,
      582.2,
      521.9,
      596.2
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b038",
    "text": "33(6): 84.",
    "bbox": [
      72.0,
      596.2,
      125.3,
      610.3
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b039",
    "text": "Bottiglieri D.",
    "bbox": [
      79.1,
      624.4,
      146.6,
      638.4
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b040",
    "text": "Crowd Pleaser. Pharmaceutical Executive.  Sep 2001; 21(9): 122.",
    "bbox": [
      146.6,
      624.4,
      477.3,
      638.4
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b041",
    "text": "008 5",
    "bbox": [
      496.0,
      654.0,
      526.6,
      666.2
    ],
    "font_size": 11.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b042",
    "text": ".0050 10",
    "bbox": [
      492.4,
      668.6,
      529.9,
      678.6
    ],
    "font_size": 9.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b043",
    "text": "Fugh-Berman A, Melnick D. Off-Label Promotion, On-Target Sales. PLoS Medicine 2",
    "bbox": [
      76.4,
      652.5,
      496.0,
      666.6
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b044",
    "text": "(10): e210 http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed",
    "bbox": [
      72.0,
      666.8,
      492.4,
      679.1
    ],
    "font_size": 11.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b045",
    "text": "4 Fugh‐Berman A. Key opinion leaders: Thus are our medical meetings monitored. BMJ",
    "bbox": [
      72.0,
      679.2,
      516.7,
      693.3
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b046",
    "text": "2008;337:a789 http://www.bmj.com/cgi/content/full/337",
    "bbox": [
      72.0,
      693.3,
      347.0,
      707.4
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 2,
    "block_id": "981_p2_b047",
    "text": "/jul15_1/a789",
    "bbox": [
      72.0,
      706.1,
      140.7,
      720.2
    ],
    "font_size": 12.0,
    "font_name": "Cambria",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b001",
    "text": "Fugh­Berman, A",
    "bbox": [
      458.8,
      36.0,
      542.6,
      50.1
    ],
    "font_size": 12.0,
    "font_name": "Cambria-Italic",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b002",
    "text": "product’s efficacy, concerns about its risks, or enthusiasm for a competing therapy will",
    "bbox": [
      72.0,
      72.2,
      531.4,
      85.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b003",
    "text": "be unceremoniously dropped from a company’s speaker’s bureau.",
    "bbox": [
      72.0,
      86.0,
      426.9,
      99.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b004",
    "text": "Vetting bias in CME modules",
    "bbox": [
      72.0,
      113.7,
      229.4,
      127.1
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b005",
    "text": "There is little incentive for medical education and communication (MEC)",
    "bbox": [
      108.0,
      127.4,
      492.8,
      140.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b006",
    "text": "companies or academic medical centers to attempt to ferret out bias in CME modules,",
    "bbox": [
      72.0,
      141.2,
      530.8,
      154.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b007",
    "text": "because both depend on industry for survival. In 2007, about half of the $2.5 billion",
    "bbox": [
      72.0,
      155.0,
      514.4,
      168.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b008",
    "text": "spent on CME came from pharmaceutical manufacturers. Seventy-two percent of the",
    "bbox": [
      72.0,
      168.8,
      525.4,
      182.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b009",
    "text": "income from events sponsored by medical education companies is from firms that",
    "bbox": [
      72.0,
      182.6,
      508.9,
      196.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b010",
    "text": "manufacture FDA-regulated products. Academic medical centers are only a little better;",
    "bbox": [
      72.0,
      196.4,
      537.5,
      209.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b011",
    "text": "57% of CME income to medical schools comes from industry.",
    "bbox": [
      72.0,
      210.2,
      404.7,
      223.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b012",
    "text": "Although academic CME providers do their best to vet industry-funded modules",
    "bbox": [
      108.0,
      224.0,
      532.9,
      237.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b013",
    "text": "for bias, such review focuses on the detection of obvious advertising, the use of brand",
    "bbox": [
      72.0,
      237.8,
      530.9,
      251.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b014",
    "text": "rather than generic names, of drugs, and adequate disclosure of conflict of interest. No",
    "bbox": [
      72.0,
      251.6,
      535.1,
      265.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b015",
    "text": "matter how vigilant they are, CME providers are not trained in recognizing marketing",
    "bbox": [
      72.0,
      265.4,
      522.2,
      278.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b016",
    "text": "messages and cannot adequately assess industry-funded materials for bias.",
    "bbox": [
      72.0,
      279.2,
      482.9,
      292.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b017",
    "text": "As previously noted, marketing begins years before a drug reaches the market.",
    "bbox": [
      108.0,
      293.0,
      531.0,
      306.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b018",
    "text": "Adequate vetting of CME modules would require knowledge of every drug, biologic,",
    "bbox": [
      72.0,
      306.8,
      517.6,
      320.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b019",
    "text": "device, and diagnostic test that every company is marketing, developing, or considering.",
    "bbox": [
      72.0,
      320.6,
      542.9,
      334.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b020",
    "text": "The task becomes even more daunting when mergers, acquisitions, co-marketing",
    "bbox": [
      72.0,
      334.4,
      507.5,
      347.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b021",
    "text": "agreements and collaborative marketing arrangements for example, among companies",
    "bbox": [
      72.0,
      348.2,
      536.8,
      361.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b022",
    "text": "selling drugs in the same class) are taken into account. Similarly, disclosures of",
    "bbox": [
      72.0,
      362.0,
      496.2,
      375.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b023",
    "text": "financial conflicts of interest are impossible to interpret without knowing every",
    "bbox": [
      72.0,
      375.8,
      484.8,
      389.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b024",
    "text": "company’s marketing plan for every drug on the market or in the pipeline.",
    "bbox": [
      72.0,
      389.6,
      463.5,
      403.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b025",
    "text": "‘Unrestricted’ grants",
    "bbox": [
      72.0,
      417.3,
      182.0,
      430.7
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b026",
    "text": "Unrestricted educational grants to academic medical centers or MECs are no",
    "bbox": [
      108.0,
      431.0,
      520.1,
      444.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b027",
    "text": "solution. Although the new PhRMA Code of Ethics does not allow sponsors (companies",
    "bbox": [
      72.0,
      444.8,
      539.5,
      458.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b028",
    "text": "that fund the event) to suggest speakers, sponsors may indicate which topics they are",
    "bbox": [
      72.0,
      458.6,
      531.0,
      472.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b029",
    "text": "interested in funding. “Unrestricted” grants provided for grand rounds and lunch",
    "bbox": [
      72.0,
      472.4,
      495.6,
      485.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b030",
    "text": "conferences depend on a sense of obligation rather than a quid pro quo. When lists of",
    "bbox": [
      72.0,
      486.2,
      531.1,
      499.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b031",
    "text": "recommended speakers are supplied to organizers, it is unstated, but nonetheless",
    "bbox": [
      72.0,
      500.0,
      511.0,
      513.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b032",
    "text": "understood, that company-paid speakers will be included in the lecture series.",
    "bbox": [
      72.0,
      513.8,
      491.5,
      527.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b033",
    "text": "The organizing board of the CME program may include speakers selected and",
    "bbox": [
      108.0,
      527.6,
      526.8,
      541.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b034",
    "text": "paid by the sponsor. The desired messages about particular products or diseases may",
    "bbox": [
      72.0,
      541.4,
      534.3,
      554.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b035",
    "text": "be made clear. Organizers understand that sponsors or exhibitors may withdraw if they",
    "bbox": [
      72.0,
      555.2,
      536.2,
      568.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b036",
    "text": "don’t like the content. Not every speaker in a lecture series or conference is chosen by",
    "bbox": [
      72.0,
      569.0,
      533.6,
      582.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b037",
    "text": "industry. Pharmaceutical companies refer to presentations with marketing messages as",
    "bbox": [
      72.0,
      582.8,
      542.9,
      596.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b038",
    "text": "“message talks,” and sponsored CME programs usually include talks that are not",
    "bbox": [
      72.0,
      596.6,
      504.3,
      610.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b039",
    "text": "connected with the sponsor’s product. Although these camouflage talks may involve",
    "bbox": [
      72.0,
      610.4,
      520.1,
      623.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b040",
    "text": "independent speakers, organizers know that they must avoid inviting speakers who",
    "bbox": [
      72.0,
      624.2,
      516.2,
      637.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b041",
    "text": "might criticize a sponsor’s products or oppose a sponsor’s marketing messages3.",
    "bbox": [
      72.0,
      636.1,
      508.5,
      651.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b042",
    "text": "Physicians will never hear about how a targeted disease is overdiagnosed or",
    "bbox": [
      108.0,
      651.8,
      518.1,
      665.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 3,
    "block_id": "981_p3_b043",
    "text": "overtreated at a sponsored event. And rarely will they hear positive recommendations",
    "bbox": [
      72.0,
      665.6,
      528.8,
      679.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b001",
    "text": "Fugh­Berman, A",
    "bbox": [
      458.8,
      36.0,
      542.6,
      50.1
    ],
    "font_size": 12.0,
    "font_name": "Cambria-Italic",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b002",
    "text": "for a competitor’s product, a generic product, or a non-pharmacologic therapy at a",
    "bbox": [
      72.0,
      72.2,
      509.7,
      85.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b003",
    "text": "sponsored program.",
    "bbox": [
      72.0,
      86.0,
      186.1,
      99.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b004",
    "text": "ACCME",
    "bbox": [
      72.0,
      113.7,
      118.7,
      127.1
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b005",
    "text": "The ACCME Standards for Commercial Support5 to discourage potential conflicts",
    "bbox": [
      108.0,
      125.6,
      543.1,
      140.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b006",
    "text": "of interest are both weak and ignored. A 2007 annual report by the ACCME, however,",
    "bbox": [
      72.0,
      141.2,
      530.4,
      154.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b007",
    "text": "showed that 29% of providers failed to comply with Standard 2, which requires that any",
    "bbox": [
      72.0,
      155.0,
      537.0,
      168.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b008",
    "text": "individuals that control content of a CME activity disclose and resolve conflicts of",
    "bbox": [
      72.0,
      168.8,
      502.2,
      182.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b009",
    "text": "interest.6 27% of the providers did not comply with Standard 3, which includes",
    "bbox": [
      72.0,
      180.8,
      489.0,
      196.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b010",
    "text": "guidelines to prevent those with commercial interest from dictating the content of a CME",
    "bbox": [
      72.0,
      196.4,
      542.3,
      209.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b011",
    "text": "activity. And 36% of providers were noncompliant with Standard 6, which requires that",
    "bbox": [
      72.0,
      210.2,
      531.7,
      223.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b012",
    "text": "all commercial support and financial relationships of authors be disclosed to CME",
    "bbox": [
      72.0,
      224.0,
      506.8,
      237.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b013",
    "text": "participants before the activity. 6",
    "bbox": [
      72.0,
      236.0,
      251.9,
      251.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b014",
    "text": "The ACCME does not screen CME activities, and does not encourage audience",
    "bbox": [
      108.0,
      251.6,
      534.9,
      265.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b015",
    "text": "members to report commercial bas. Although written complaints are accepted, the",
    "bbox": [
      72.0,
      265.4,
      510.3,
      278.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b016",
    "text": "process is burdensome The ACCME would not tell us whether or not any providers",
    "bbox": [
      72.0,
      279.2,
      514.9,
      292.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b017",
    "text": "have lost accreditation status due to commercial bias. Losing accreditation for any",
    "bbox": [
      72.0,
      293.0,
      510.2,
      306.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b018",
    "text": "reason is rare; according to the annual reports published by the ACCME only one",
    "bbox": [
      72.0,
      306.8,
      507.0,
      320.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b019",
    "text": "provider lost accreditation in 2005.",
    "bbox": [
      72.0,
      320.6,
      261.4,
      334.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b020",
    "text": "Conclusion",
    "bbox": [
      72.0,
      348.3,
      134.7,
      361.7
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b021",
    "text": "If sponsoring CME events did not increase product sales, drug companies would",
    "bbox": [
      108.0,
      362.0,
      538.2,
      375.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b022",
    "text": "not do it. The large amount of commercial support poured into CME is in itself testimony",
    "bbox": [
      72.0,
      375.8,
      541.1,
      389.2
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b023",
    "text": "that industry believes supporting CME is cost-effective.  Industry influence on medical",
    "bbox": [
      72.0,
      389.6,
      528.7,
      403.0
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b024",
    "text": "discourse limits the discussion to the most profitable therapies, which may not be best",
    "bbox": [
      72.0,
      403.4,
      530.8,
      416.8
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b025",
    "text": "for patients. Industry-funded medical education is a contradiction in terms.",
    "bbox": [
      72.0,
      417.2,
      467.6,
      430.6
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b026",
    "text": "###",
    "bbox": [
      296.0,
      445.0,
      319.4,
      458.4
    ],
    "font_size": 12.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b027",
    "text": "Acknowledgments: Alicia Bell MS, Margaret Infeld, Clare Murphy, Stephanie",
    "bbox": [
      72.0,
      472.9,
      479.6,
      486.3
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b028",
    "text": "Waterhouse, and Nicole Woodard provided background research.",
    "bbox": [
      72.0,
      486.7,
      424.3,
      500.1
    ],
    "font_size": 12.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b029",
    "text": "About PharmedOut",
    "bbox": [
      72.0,
      514.4,
      166.5,
      525.6
    ],
    "font_size": 10.0,
    "font_name": "Arial-BoldItalicMT",
    "label": "HH1"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b030",
    "text": "PharmedOut, a project based at Georgetown University Medical Center, uses academic research",
    "bbox": [
      108.0,
      537.2,
      542.8,
      548.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b031",
    "text": "and drug industry insider perspectives to educate prescribers about how covert marketing techniques",
    "bbox": [
      72.0,
      548.8,
      542.8,
      559.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b032",
    "text": "affect prescribing behavior. PharmedOut was launched through a grant from the Attorney General",
    "bbox": [
      72.0,
      560.2,
      542.8,
      571.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b033",
    "text": "Consumer and Prescriber Grant Program.",
    "bbox": [
      72.0,
      571.7,
      263.1,
      582.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b034",
    "text": "Our latest free, web-based, 3-CME credit educational module is called The Pharmalyzer: Are you",
    "bbox": [
      108.0,
      583.3,
      542.8,
      594.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b035",
    "text": "prescribing under the influence? Our unique approach draws on academic and marketing materials",
    "bbox": [
      72.0,
      594.7,
      542.8,
      605.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b036",
    "text": "5 ACCME. Essential Areas and Elements; 2008  Available via the Internet:",
    "bbox": [
      72.0,
      621.1,
      401.1,
      633.5
    ],
    "font_size": 10.0,
    "font_name": "Calibri",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b037",
    "text": "ttp://www.accme.org/dir_docs/doc_upload/f4ee5075-9574-4231-8876-",
    "bbox": [
      77.6,
      633.8,
      387.8,
      645.0
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b038",
    "text": "5e21723c0c82_uploaddocument.pdf. Accessed June 30, 2009",
    "bbox": [
      72.0,
      645.4,
      351.6,
      656.5
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b039",
    "text": "6 ACCME [Standards for Commercial Support; 2008 Available via the Internet:",
    "bbox": [
      72.0,
      670.4,
      418.8,
      682.7
    ],
    "font_size": 10.0,
    "font_name": "Calibri",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b040",
    "text": "ttp://www.accme.org/dir_docs/doc_upload/68b2902a-fb73-44d1-8725-",
    "bbox": [
      77.6,
      683.1,
      387.8,
      694.3
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 4,
    "block_id": "981_p4_b041",
    "text": "80a1504e520c_uploaddocument.pdf. Accessed June 30, 2009.",
    "bbox": [
      72.0,
      694.6,
      354.9,
      705.8
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b001",
    "text": "Fugh­Berman, A",
    "bbox": [
      458.8,
      36.0,
      542.6,
      50.1
    ],
    "font_size": 12.0,
    "font_name": "Cambria-Italic",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b002",
    "text": "combined with original interviews with industry insiders to create novel articles, videos, and educational",
    "bbox": [
      72.0,
      72.2,
      542.7,
      83.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b003",
    "text": "materials. Our goal is to foster evidence-based, cost-effective prescribing and to decrease the adverse",
    "bbox": [
      72.0,
      83.7,
      542.8,
      94.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b004",
    "text": "public health effects of inappropriate pharmaceutical promotion.",
    "bbox": [
      72.0,
      95.2,
      358.8,
      106.3
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b005",
    "text": "We provide original web-based CME modules and links to more than 150 free, non-industry-",
    "bbox": [
      108.0,
      106.7,
      540.0,
      117.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b006",
    "text": "funded, web-based continuing medical education (CME) courses – enough for any physician, nurse, or",
    "bbox": [
      72.0,
      118.2,
      542.7,
      129.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b007",
    "text": "pharmacist to complete annual continuing education requirements. Educational resources include our",
    "bbox": [
      72.0,
      129.7,
      542.8,
      140.8
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b008",
    "text": "slideshows, Drug Ad Bingo (a teaching exercise), Fast Facts on Generic Drugs (a factsheet for patients),",
    "bbox": [
      72.0,
      141.2,
      542.8,
      152.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b009",
    "text": "and seven original videos, featuring industry insiders. Our publications include Off-Label Promotion, On-",
    "bbox": [
      72.0,
      152.7,
      540.0,
      163.9
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b010",
    "text": "Target Sales,Following the Script: How Drug Reps Make Friends and Influence Doctors, Do New Drugs",
    "bbox": [
      72.0,
      164.2,
      542.8,
      175.4
    ],
    "font_size": 10.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b011",
    "text": "Increase Life Expectancy?, Ethical Considerations of Publication Planning in the Pharmaceutical Industry,",
    "bbox": [
      72.0,
      175.7,
      542.8,
      186.9
    ],
    "font_size": 10.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b012",
    "text": "Prescription Tracking and Public Health, Key Opinion Leaders: Thus Are Our Medical Meetings Managed,",
    "bbox": [
      72.0,
      187.3,
      542.8,
      198.4
    ],
    "font_size": 10.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b013",
    "text": "and Smoke and Mirrors.",
    "bbox": [
      72.0,
      198.7,
      181.5,
      209.9
    ],
    "font_size": 10.0,
    "font_name": "Arial-ItalicMT",
    "label": "BODY"
  },
  {
    "pdf_id": "981",
    "page_number": 5,
    "block_id": "981_p5_b014",
    "text": "i Raichle L. Proving the case for investing in CME. Medical Marketing & Media. Jun 1998; 33(6): 84.",
    "bbox": [
      72.0,
      237.5,
      514.1,
      249.4
    ],
    "font_size": 10.0,
    "font_name": "ArialMT",
    "label": "BODY"
  }
]